Overview
Sida Qin practices practicing medicine in Xi'an, China.
Their clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Breast Cancer, and Lung Adenocarcinoma.
They are actively involved in clinical research, co-authoring 44 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Sida D. Qin
Is Sida D. Qin a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Sida D. Qin is classified as an Experienced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Sida D. Qin participate in research or clinical trials?
Yes. Sida D. Qin has published 44 articles and abstracts on conditions like Lung Cancer. You can view a list of Sida D. Qin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Breast CancerQin isExperienced. Learn about Breast Cancer.
- Lung AdenocarcinomaQin isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerQin isExperienced. Learn about Lung Cancer.
- Lung MetastasesQin isExperienced. Learn about Lung Metastases.
- Non-Small Cell Lung Cancer (NSCLC)
- Triple-Negative Breast Cancer